- Home
- TMP vs PRTA Comparison
TMP vs PRTA Comparison
Compare TMP & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMP
- PRTA
- Stock Information
- Founded
- TMP 1836
- PRTA 2012
- Country
- TMP United States
- PRTA Ireland
- Employees
- TMP N/A
- PRTA N/A
- Industry
- TMP Major Banks
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- TMP Finance
- PRTA Health Care
- Exchange
- TMP Nasdaq
- PRTA Nasdaq
- Market Cap
- TMP 894.9M
- PRTA 809.8M
- IPO Year
- TMP N/A
- PRTA N/A
- Fundamental
- Price
- TMP $59.20
- PRTA $9.70
- Analyst Decision
- TMP Buy
- PRTA Buy
- Analyst Count
- TMP 2
- PRTA 9
- Target Price
- TMP $69.00
- PRTA $54.57
- AVG Volume (30 Days)
- TMP 52.6K
- PRTA 605.6K
- Earning Date
- TMP 04-25-2025
- PRTA 05-07-2025
- Dividend Yield
- TMP 4.19%
- PRTA N/A
- EPS Growth
- TMP 653.03
- PRTA N/A
- EPS
- TMP 4.97
- PRTA N/A
- Revenue
- TMP $292,618,000.00
- PRTA $135,157,000.00
- Revenue This Year
- TMP $12.86
- PRTA N/A
- Revenue Next Year
- TMP $7.68
- PRTA $131.71
- P/E Ratio
- TMP $11.90
- PRTA N/A
- Revenue Growth
- TMP 35.84
- PRTA 47.92
- 52 Week Low
- TMP $43.32
- PRTA $9.00
- 52 Week High
- TMP $79.01
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- TMP 47.24
- PRTA 34.03
- Support Level
- TMP $58.02
- PRTA $9.00
- Resistance Level
- TMP $61.12
- PRTA $10.07
- Average True Range (ATR)
- TMP 2.84
- PRTA 0.74
- MACD
- TMP 0.48
- PRTA 0.07
- Stochastic Oscillator
- TMP 62.92
- PRTA 28.00
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).